Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial - Mazighi, M; Köhrmann, M; Lemmens, R; ACTIMIS Study Group (Lancet Neurol, 2024)